ADRDA Stock Overview
Develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. More details
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Adherium Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.031 |
52 Week High | AU$0.033 |
52 Week Low | AU$0.025 |
Beta | 2.4 |
1 Month Change | n/a |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 24.00% |
Recent News & Updates
Recent updates
Shareholder Returns
ADRDA | AU Healthcare Services | AU Market | |
---|---|---|---|
7D | 14.8% | -6.7% | -1.7% |
1Y | n/a | 145.4% | 10.5% |
Return vs Industry: Insufficient data to determine how ADRDA performed against the Australian Healthcare Services industry.
Return vs Market: Insufficient data to determine how ADRDA performed against the Australian Market.
Price Volatility
ADRDA volatility | |
---|---|
ADRDA Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 10.8% |
Market Average Movement | 8.2% |
10% most volatile stocks in AU Market | 17.4% |
10% least volatile stocks in AU Market | 3.1% |
Stable Share Price: ADRDA has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ADRDA's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | n/a | Rick Legleiter | www.adherium.com |
Adherium Limited develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie, an asthma and chronic obstructive pulmonary disease medication adherence solution for patients with chronic respiratory diseases. It also provides Bluetooth enabled Hailie sensors, which wrap around patient inhalers and offers real-time feedback to patients; Hailie app; and Hailie portal, as well as Hailie remote patient management solution.
Adherium Limited Fundamentals Summary
ADRDA fundamental statistics | |
---|---|
Market cap | AU$10.34m |
Earnings (TTM) | -AU$9.86m |
Revenue (TTM) | AU$3.20m |
3.2x
P/S Ratio-1.0x
P/E RatioIs ADRDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ADRDA income statement (TTM) | |
---|---|
Revenue | AU$3.20m |
Cost of Revenue | AU$670.00k |
Gross Profit | AU$2.53m |
Other Expenses | AU$12.38m |
Earnings | -AU$9.86m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.03 |
Gross Margin | 79.03% |
Net Profit Margin | -308.54% |
Debt/Equity Ratio | 0% |
How did ADRDA perform over the long term?
See historical performance and comparison